Lex M van Loon Selected Research

Lex M van Loon Research Topics

3	COVID-19 01/2022 - 01/2021
3	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2018
3	Sepsis (Septicemia) 12/2019 - 01/2018
2	Lung Injury 01/2022 - 01/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2021
2	Thrombosis (Thrombus) 01/2022 - 01/2021
1	Delirium 09/2023
1	Infections 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Inflammation (Inflammations) 01/2020
1	Endotoxemia 01/2020
1	Shock 01/2018
1	Hyperemia 01/2018
1	Coma (Comas) 01/2017
1	Heart Arrest (Cardiac Arrest) 01/2017

3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2021
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 01/2020
2	LipopolysaccharidesIBA 12/2019 - 01/2018
2	esmolol (Brevibloc)FDA LinkGeneric 12/2019 - 01/2018
1	FibrinIBA 01/2022
1	AnticoagulantsIBA 01/2021
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Vasoconstrictor AgentsIBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2019

3	Resuscitation 01/2021 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 09/2023 - 01/2021
2	Therapeutics 01/2022 - 01/2020
1	Length of Stay 09/2023
1	MT protocol 01/2022
1	Anesthesia 12/2019
1	Critical Care (Surgical Intensive Care) 01/2019
1	Induced Hypothermia 01/2017